| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lenalidomide | FAERS: 194 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 2 | pomalidomide | FAERS: 40 | US FAERS | |
| 3 | Bortezomib | FAERS: 30 | US FAERS | |
| 4 | carfilzomib | FAERS: 15 | US FAERS | |
| 5 | Zoledronic Acid | FAERS: 9 | US FAERS | |
| 6 | Thalidomide | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | ixazomib | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Panobinostat | FAERS: 1 | US FAERS | |
| 9 | Varenicline | FAERS: 1 | US FAERS | |
| 10 | Warfarin | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.